se of combined FDG-PET/CT in diagnosing infectious complications in patients treated with intensive chemotherapy and stem cell transplant recipients for haematological malignancy.
- Conditions
- febriele neutropeniefebrile neutropeniafever after chemotherapy1001886510017528
- Registration Number
- NL-OMON30325
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
- admission and treatment at the department of hematology because of a hematological malignancy
- expected duration of neutropenia >7 days;and any of the following:
* C-reactive proteïn > 50 mg/l
* febrile neutropenia > 3-4 days despite aimed empirical or aimed antibiotic therapy
* persistant bacteraemia with coagulase negative Staphylococci
* pulmonary HRCT inidicated because of suspected pulmonary Aspergillosis
Exclusion Criteria
- hemodynamic instablility
- diabetus millitus in which insulin has to be administered within 4 hours of the PET-scan either bloodglucose levels exceed 15 mmol.l
- pregnancy or lactation
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method